Literature DB >> 11281455

TSC1 and TSC2 deletions differ in size, preference for recombinatorial sequences, and location within the gene.

L Longa1, A Saluto, A Brusco, S Polidoro, S Padovan, A Allavena, C Carbonara, E Grosso, N Migone.   

Abstract

Large TSC gene rearrangements are not rare findings in tuberous sclerosis. Interestingly, all deletions, duplications and inversions so far described involve TSC2, none being associated with TSC1. In order to shed light on the structural basis of the preferential DNA rearrangements in TSC2 over TSC1 and to assess, in an unselected patient population, the prevalence of large re-arrangements in both TSC loci, we screened 202 tuberous sclerosis patients consecutively referred at our center. Southern blot analysis on EcoRI+HindIII double-digested DNA identified 19 partial or full-length gene deletions: three involved TSC1 and sixteen TSC2. The breakpoint sequence of seven internal deletions, three in TSC1 and four in TSC2, allowed us to speculate on the mechanism favoring TSC2 unequal recombinations and to identify a deletion hot spot that lies in TSC1 and that may be relevant in the routine genetic testing of tuberous sclerosis. Briefly, three major features appear to distinguish TSC1 from TSC2 deletions: (1) deletion size: all TSC1 deletions are within the transcriptional unit, whereas 12 of the 16 TSC2 deletions have at least one external breakpoint; (2) location within the gene: all TSC1 deletions are confined to the 3'end of the gene (all three 5' breakpoints being located in intron 20) thus resulting in the same frameshift mutation following amino acid K875, whereas the TSC2 internal breakpoints appear to be scattered along the gene; (3) preference for recombinatorial sequences: six out of eight internal TSC2 breakpoints map within Alu repeats, whereas none of the three TSC1 deletions appear to be Alu-mediated. Indeed, in the latter gene, unique structural features (a purine-rich tract flanked by pyrimidine-rich segments) surrounding one of the two identified breakpoint cluster regions might play a role in promoting inappropriate recombinations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11281455     DOI: 10.1007/s004390100460

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  6 in total

1.  Characterisation of TSC1 promoter deletions in tuberous sclerosis complex patients.

Authors:  Ans M W van den Ouweland; Peter Elfferich; Bernard A Zonnenberg; Willem F Arts; Tjitske Kleefstra; Mark D Nellist; Jose M Millan; Caroline Withagen-Hermans; Anneke J A Maat-Kievit; Dicky J J Halley
Journal:  Eur J Hum Genet       Date:  2010-09-29       Impact factor: 4.246

2.  Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations.

Authors:  Piotr Kozlowski; Penelope Roberts; Sandra Dabora; David Franz; John Bissler; Hope Northrup; Kit Sing Au; Ross Lazarus; Dorota Domanska-Pakiela; Katarzyna Kotulska; Sergiusz Jozwiak; David J Kwiatkowski
Journal:  Hum Genet       Date:  2007-02-08       Impact factor: 4.132

3.  Molecular and clinical analyses of 84 patients with tuberous sclerosis complex.

Authors:  Chia-Cheng Hung; Yi-Ning Su; Shu-Chin Chien; Horng-Huei Liou; Chih-Chuan Chen; Pau-Chung Chen; Chia-Jung Hsieh; Chih-Ping Chen; Wang-Tso Lee; Win-Li Lin; Chien-Nan Lee
Journal:  BMC Med Genet       Date:  2006-09-18       Impact factor: 2.103

4.  Correlations between long inverted repeat (LIR) features, deletion size and distance from breakpoint in human gross gene deletions.

Authors:  Nevim Aygun
Journal:  Sci Rep       Date:  2015-02-06       Impact factor: 4.379

5.  Conjunctival lymphangioma in a 4-year-old girl revealed tuberous sclerosis complex.

Authors:  Florentina Joyce Freiberg; Erdmute Kunstmann; Thomas König; Juliane Matlach; Daniel Kampik
Journal:  GMS Ophthalmol Cases       Date:  2016-09-02

6.  Molecular analysis of TSC1 and TSC2 genes and phenotypic correlations in Brazilian families with tuberous sclerosis.

Authors:  Clévia Rosset; Filippo Vairo; Isabel Cristina Bandeira; Rudinei Luis Correia; Fernanda Veiga de Goes; Raquel Tavares Boy da Silva; Larissa Souza Mario Bueno; Mireille Caroline Silva de Miranda Gomes; Henrique de Campos Reis Galvão; João I C F Neri; Maria Isabel Achatz; Cristina Brinckmann Oliveira Netto; Patricia Ashton-Prolla
Journal:  PLoS One       Date:  2017-10-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.